Physician profile
John Pointer Eitzen
NPI 1124218698
$2,455.81
in general payments reported to CMS, 2019-2025
15 companies · $751 in 2025
The $751 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $109 · 2021: $99.96 · 2022: $314 · 2023: $475 · 2024: $707 · 2025: $751.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,933.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,933.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $772.13 | 2022-2025 | Rocklatan, Clareon, Simbrinza |
| Abbvie INC. | $586.74 | 2022-2025 | |
| Bausch & Lomb Americas INC. | $174.65 | 2023-2025 | Vyzulta, Xiidra, Miebo |
| Allergan, INC. | $142.45 | 2020-2021 | |
| Alexion Pharmaceuticals, INC. | $122.47 | 2023-2024 | Ultomiris |
| Thea Pharma INC. | $117.41 | 2023-2025 | Iyuzeh |
| Tarsus Pharmaceuticals, INC. | $111.17 | 2024-2025 | Xdemvy |
| Sight Sciences, INC. | $100.52 | 2025 | Omni Surgical System, Sion Surgical Instrument |
| Oyster Point Pharma, INC. | $80.89 | 2022-2023 | Tyrvaya |
| Sun Pharmaceutical Industries INC. | $79.36 | 2020-2025 | Cequa |
| Novartis Pharmaceuticals Corporation | $78.41 | 2022 | |
| Mallinckrodt Hospital Products INC. | $40.45 | 2025 | Acthar |
| Kala Pharmaceuticals, INC. | $18.53 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $18.10 | 2020 | |
| Glaukos Corporation | $12.53 | 2023 | Is3-Istent Infinitetrabecular Micro-Bypass System Model Is3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Eitzen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.